Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of normalizing the neutrophil to lymphocyte ratio in cancer patients with a selective glucocorticoid receptor antagonist

Method of normalizing the neutrophil to lymphocyte ratio in cancer patients with a selective glucocorticoid receptor antagonist

US Patent 12440487 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

System and method for locating wireless accessories2025
Treatments for amyotrophic lateral sclerosis using dazucorilant2025
Intermittent dosing of glucocorticoid receptor modulators for the treatment of o2024
System and method for locating wireless accessories2024
Concomitant administration of glucocorticoid receptor modulator relacorilant and2024
System and method for locating wireless accessories2023
System and method for locating wireless accessories2023
Methods of treating cancer comprising administration of a glucocorticoid recepto2022
Methods of treating cancer comprising administration of a glucocorticoid recepto2022
Concomitant administration of glucocorticoid receptor modulator relacorilant and2022
Methods of treating cancer comprising administration of a glucocorticoid recepto2022
Methods of treating cancer comprising administration of a glucocorticoid recepto2022